# Early Diagnosis as Strategy in Reducing the Incidence of Contrast-induced Nephropathy

> **NCT04225013** · — · COMPLETED · sponsor: **R. Laura Vicente Vicente** · enrollment: 150 (actual)

## Conditions studied

- Kidney Injury
- Contrast-induced Nephropathy

## Interventions

- **DIAGNOSTIC_TEST:** Early kidney damage biomarkers
- **DIAGNOSTIC_TEST:** Predisposition to kidney injury biomarkers

## Key facts

- **NCT ID:** NCT04225013
- **Lead sponsor:** R. Laura Vicente Vicente
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-01
- **Primary completion:** 2018-06-01
- **Final completion:** 2018-06-01
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2024-09-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04225013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04225013, "Early Diagnosis as Strategy in Reducing the Incidence of Contrast-induced Nephropathy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04225013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*